‘It’s going very well’: Hope rises for Oxford’s malaria vaccine after success of Covid jab from same team

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. “That’s why we’re going into phase three,” Prof Hill said, marking the second only time in history that a vaccine candidate for malaria has reached this stage of development. “Unlike viruses which maybe have 10 genes, and you can often pick the one you should target as it’s the one on the outside, malaria has 5,000,” Prof Hill said. So we think in a few years most African children will not just be getting three doses of our vaccine when they’re infants, but a dose every year to see them through to five years of age.” As with Oxford’s coronavirus vaccine, the Jenner Institute has teamed up with the Serum Institute of India to manufacture the malaria jab, with between up to 300 million doses set to be supplied by the pharmaceutical giant. open image in gallery The malaria vaccine is yet another example, she said, of the revolutionary “impact science can have on tackling global disease threats.” James Whiting, CEO of the charity Malaria No More UK, said: “The Jenner Institute’s groundbreaking work on both the new Covid-19 and malaria vaccines demonstrates just how much humanity’s safety is dependent on new science.” Both warned that recent government cuts to overseas development aid is threatening to undermine the progress that has been made in combating malaria.